Pegfilgrastim

Plinabulin demonstrated similar efficacy to pegfilgrastim for the prevention of chemotherapy-induced neutropenia, according to results of a randomized phase 3 study published in JAMA Network Open.

Omitting routine prophylactic pegfilgrastim during the paclitaxel portion of treatment appeared safe and feasible for certain patients with breast cancer, according to study results published in Journal of Clinical Oncology.

At our center, metrics obtained through our participation in CMS’s Oncology Care Model have allowed us to improve patient experience scores, reduce ED utilization and hospital admission, and impact several other measures of quality care.